Transformed human pluripotent stem cells and associated methods
a technology of human pluripotent stem cells and stem cells, applied in the field of stem cells, can solve the problems of underutilized stem cells in this field, unable to fully investigate the functional role of specific tfs responsible for retaining sc state in cancer, and inability to use large-scale cell culture to achieve high-throughput cell culture, improve growth rate and niche independence, and reduce differentiation potential in vitro
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Characterization of Human Embryonic Stem Cells with Features of Neoplastic Progression
[0127]The acquisition of genetic and epigenetic abnormalities in human embryonic stem (hES) cell lines has raised safety concerns about the use of these cells in regenerative medicine (1-14). Indeed, the finding that aggressive cancers express hES cell-associated genes (15) suggests that hES cells are vulnerable to neoplastic progression. In the context of clinical application, it will therefore be important to detect the emergence of cancerous cells among normal hES cells. This is a challenging task given that hES cells with cancer-cell characteristics may resemble normal hES cells with respect to properties such as self-renewal, teratoma formation and the expression of pluripotency markers. Most studies that have examined transformation of hES cells have been limited to determination of karyotypic abnormalities and did not include extensive functional characterization (2-9,12,13). At the cellular...
example 2
Screening Methods and Assays that Use Transformed Pluripotent Stem Cells
[0168]In this example, the Applicants demonstrate the use of transformed pluripotent stem cells in cell-based screening assays. In some embodiments, the t-hPSCs are used in High Throughput Screening (HTS) assays and optionally for drug discovery.
[0169]The Applicants describe assays that use the t-hPSCs described herein for determining loss of pluripotency / differentiation. In particular, EOS OCT4 reporter v-hESC-1 cell lines have been generated and tested in a high throughput format.
[0170]The Applicants also describe the use of t-hPSCs in assays to for determining apoptotic or anti-cancer activity of a compound, composition or reagent in brought into contact with t-hPSCs.
[0171]A person skilled in the art will appreciate that the methods and assays described herein may also use derivatives of the t-hPSCs cell lines described herein created by means of spontaneous or induced differentiation.
Transformed Pluripotent ...
example 3
Generation of Transformed Induced Pluripotent Stem (t-iPS) Cells
[0188]Here, the Applicants describe the derivation of transformed pluripotent stem cells from normal iPS cell lines created after skin fibroblast genetic reprogramming. These cells show several characteristics that are similar to transformed ES including morphological similarities, high prevalence of SSEA3 cells, compromised differentiation and growth factor bFGF independence.
[0189]Referring to FIG. 13, phase contrast images of morphological data illustrates the differential characteristics between normal induced pluripotent stem cells (iPSCs) (FIG. 13a-b) and transformed induced pluripotent stem cells (tiPSCs) (FIG. 13c-f). Normal iPSC morphology consists of a colony with a well-defined border separating it from the surrounding fibroblast-like cells depicted in B (black arrow). In addition, normal iPSCs produce supportive fibroblast-like cells shown in 13A (white arrow). Transformed iPSCs on the other hand do not posse...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More